| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.5 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.5 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |